260266
1,2-环氧十四烷
technical grade, 85%
登录 查看组织和合同定价。
选择尺寸
关于此项目
经验公式（希尔记法）:
C14H28O
化学文摘社编号:
分子量:
212.37
NACRES:
NA.23
PubChem Substance ID:
UNSPSC Code:
12162002
EC Number:
221-781-6
MDL number:
产品名称
1,2-环氧十四烷, technical grade, 85%
InChI key
IOHJQSFEAYDZGF-UHFFFAOYSA-N
InChI
1S/C14H28O/c1-2-3-4-5-6-7-8-9-10-11-12-14-13-15-14/h14H,2-13H2,1H3
SMILES string
CCCCCCCCCCCCC1CO1
grade
technical grade
assay
85%
form
liquid
refractive index
n20/D 1.4408 (lit.)
bp
95-96 °C/0.4 mmHg (lit.)
density
0.845 g/mL at 25 °C (lit.)
signalword
Warning
hcodes
Hazard Classifications
Aquatic Acute 1 - Aquatic Chronic 1 - Skin Irrit. 2
存储类别
10 - Combustible liquids
wgk
WGK 1
flash_point_f
221.0 °F - closed cup
flash_point_c
105 °C - closed cup
ppe
Eyeshields, Gloves, type ABEK (EN14387) respirator filter
Ping Song et al.
Molecular therapy : the journal of the American Society of Gene Therapy, 27(8), 1424-1435 (2019-06-04)
Interleukin-1 beta (IL-1β) plays a central role in the induction of rheumatoid arthritis (RA). In the present study, we demonstrated that lipidoid-polymer hybrid nanoparticle (FS14-NP) can efficiently deliver siRNA against IL-1β (siIL-1β) to macrophages and effectively suppress the pathogenesis of
Eva Ramsay et al.
Pharmaceutics, 12(7) (2020-07-28)
Inflammation is involved in the pathogenesis of several age-related ocular diseases, such as macular degeneration (AMD), diabetic retinopathy, and glaucoma. The delivery of anti-inflammatory siRNA to the retinal pigment epithelium (RPE) may become a promising therapeutic option for the treatment
Shantipriya Khadka et al.
Electrophoresis, 37(23-24), 3160-3171 (2016-09-10)
A novel precursor monolithic capillary column referred to as "hydroxy monolith" or OHM was prepared by the in situ copolymerization of hydroxyethylmethacrylate (HEMA) with pentaerythritol triacrylate (PETA) yielding the neutral poly(HEMA-co-PETA) monolith. The neutral precursor OHM capillary thus obtained was
Wei Tao et al.
Science translational medicine, 12(553) (2020-07-29)
Atherosclerotic lesional macrophages express molecules that promote plaque progression, but lack of mechanisms to therapeutically target these molecules represents a major gap in translational cardiovascular research. Here, we tested the efficacy of a small interfering RNA (siRNA) nanoparticle (NP) platform
Rachel S Riley et al.
Science advances, 7(3) (2021-02-02)
Clinical advances enable the prenatal diagnosis of genetic diseases that are candidates for gene and enzyme therapies such as messenger RNA (mRNA)-mediated protein replacement. Prenatal mRNA therapies can treat disease before the onset of irreversible pathology with high therapeutic efficacy
我们的科学家团队拥有各种研究领域经验，包括生命科学、材料科学、化学合成、色谱、分析及许多其他领域.
联系客户支持